ABP, the open-source end-to-end .NET application development platform, has enhanced the user experience by consolidating all its services under a single address, ABP.IO. This update simplifies ...
IRVINE, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex ...
ABP, the open-source end-to-end .NET application development platform, has enhanced the user experience by consolidating all its services under a single address, ABP.IO. This update simplifies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results